Viridian Therapeutics Inc. monthly returns
Viridian Therapeutics Inc. has averaged 1.22% per month, positive in 42% of months. Month-by-month returns for Viridian Therapeutics Inc. (VRDN) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Viridian Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -7.6% | |
| Sep 2026 | -11.1% | |
| Aug 2026 | +22.4% | |
| Jul 2026 | +3.0% | |
| Jun 2026 | +4.3% | |
| May 2026 | +30.7% | |
| Apr 2026 | -31.1% | |
| Mar 2026 | -33.4% | |
| Feb 2026 | -11.0% | |
| Jan 2026 | +6.0% | |
| Dec 2025 | -2.6% | |
| Nov 2025 | +35.3% | |
| Oct 2025 | +9.5% | |
| Sep 2025 | +17.4% | |
| Aug 2025 | +4.9% | |
| Jul 2025 | +25.3% | |
| Jun 2025 | +0.4% | |
| May 2025 | +2.7% | |
| Apr 2025 | +0.5% | |
| Mar 2025 | -13.2% | |
| Feb 2025 | -19.9% | |
| Jan 2025 | +1.1% | |
| Dec 2024 | -11.0% | |
| Nov 2024 | -0.1% | |
| Oct 2024 | -5.2% | |
| Sep 2024 | +55.0% | |
| Aug 2024 | -12.9% | |
| Jul 2024 | +29.5% | |
| Jun 2024 | +8.9% | |
| May 2024 | -9.9% | |
| Apr 2024 | -24.3% | |
| Mar 2024 | -6.4% | |
| Feb 2024 | -2.8% | |
| Jan 2024 | -11.6% | |
| Dec 2023 | +30.1% | |
| Nov 2023 | +33.9% | |
| Oct 2023 | -18.5% | |
| Sep 2023 | -15.6% | |
| Aug 2023 | -3.1% | |
| Jul 2023 | -21.1% | |
| Jun 2023 | -0.2% | |
| May 2023 | -15.0% | |
| Apr 2023 | +10.2% | |
| Mar 2023 | -22.3% | |
| Feb 2023 | -10.3% | |
| Jan 2023 | +25.0% | |
| Dec 2022 | +15.6% | |
| Nov 2022 | +27.0% | |
| Oct 2022 | -3.0% | |
| Sep 2022 | -7.7% | |
| Aug 2022 | +67.7% | |
| Jul 2022 | +14.4% | |
| Jun 2022 | -5.2% | |
| May 2022 | -11.3% | |
| Apr 2022 | -25.6% | |
| Mar 2022 | +2.3% | |
| Feb 2022 | -10.1% | |
| Jan 2022 | +1.7% | |
| Dec 2021 | +2.8% | |
| Nov 2021 | +6.3% | |
| Oct 2021 | +10.0% | |
| Sep 2021 | +22.9% | |
| Aug 2021 | -13.8% | |
| Jul 2021 | -15.1% | |
| Jun 2021 | +1.6% | |
| May 2021 | -1.3% | |
| Apr 2021 | +9.2% | |
| Mar 2021 | +1.6% | |
| Feb 2021 | -7.7% | |
| Jan 2021 | +8.3% | |
| Dec 2020 | -6.7% | |
| Nov 2020 | -10.2% | |
| Oct 2020 | +69.0% | |
| Sep 2020 | -16.3% | |
| Aug 2020 | -16.6% | |
| Jul 2020 | +0.0% | |
| Jun 2020 | +12.5% | |
| May 2020 | +58.7% | |
| Apr 2020 | +39.5% | |
| Mar 2020 | -40.0% | |
| Feb 2020 | -57.5% | |
| Jan 2020 | +264.6% | |
| Dec 2019 | -40.0% | |
| Nov 2019 | +24.0% | |
| Oct 2019 | -11.8% | |
| Sep 2019 | -36.4% | |
| Aug 2019 | -42.5% | |
| Jul 2019 | -2.4% | |
| Jun 2019 | -13.5% | |
| May 2019 | -19.1% | |
| Apr 2019 | +5.0% | |
| Mar 2019 | -0.4% | |
| Feb 2019 | -2.1% | |
| Jan 2019 | -5.6% | |
| Dec 2018 | -12.9% | |
| Nov 2018 | -19.4% | |
| Oct 2018 | -22.6% | |
| Sep 2018 | -10.1% | |
| Aug 2018 | -7.9% | |
| Jul 2018 | +5.1% | |
| Jun 2018 | -9.3% | |
| May 2018 | +3.1% | |
| Apr 2018 | -2.1% | |
| Mar 2018 | +26.3% | |
| Feb 2018 | -26.0% | |
| Jan 2018 | -28.1% | |
| Dec 2017 | +30.9% | |
| Nov 2017 | -3.7% | |
| Oct 2017 | -9.5% | |
| Sep 2017 | +1.7% | |
| Aug 2017 | -34.2% | |
| Jul 2017 | +5.8% | |
| Jun 2017 | +18.4% | |
| May 2017 | -15.4% | |
| Apr 2017 | +3.8% | |
| Mar 2017 | -5.1% | |
| Feb 2017 | +44.5% | |
| Jan 2017 | +81.0% | |
| Dec 2016 | -47.3% | |
| Nov 2016 | +76.4% |
Monthly total return (since Nov 2021)#
Viridian Therapeutics Inc. returns by calendar month#
Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -7.58% — 6th of 12 Octobers since 2015 at the last close; the average October returned -1.9%.
| Month | −265%0+265% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +26.9% | +3.9% | 67% | +264.6% 2020 | -28.1% 2018 | |
| Feb | -8.3% | -8.9% | 17% | +44.5% 2017 | -57.5% 2020 | |
| Mar | -10.1% | -8.5% | 25% | +26.3% 2018 | -40.0% 2020 | |
| Apr | +0.0% | +2.1% | 58% | +39.5% 2020 | -31.1% 2026 | |
| May | +0.8% | -6.7% | 33% | +58.7% 2020 | -19.1% 2019 | |
| Jun | +0.9% | +1.0% | 58% | +21.0% 2015 | -28.0% 2016 | |
| Jul | +2.6% | +4.1% | 58% | +29.5% 2024 | -28.8% 2015 | |
| Aug | -4.5% | -10.4% | 25% | +67.7% 2022 | -42.5% 2019 | |
| Sep | -2.1% | -8.9% | 42% | +55.0% 2024 | -36.4% 2019 | |
| Oct | -1.9% | -9.5% | 27% | +69.0% 2020 | -28.2% 2016 | |
| Nov | +18.0% | +24.0% | 64% | +76.4% 2016 | -19.4% 2018 | |
| Dec | -6.5% | -6.7% | 36% | +30.9% 2017 | -47.3% 2016 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from VRDN's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Viridian Therapeutics Inc.'s average monthly return?
- Viridian Therapeutics Inc. (VRDN) has averaged about 1.22% per month, positive in roughly 42% of months. The best month was Jan 2020 (+264.6%) and the worst was Feb 2020 (-57.5%).
